ExodusPoint Capital Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,254
| Closed | -$547K | – | 1645 |
|
|
2024
Q1 | $547K | Buy |
12,254
+9,709
| +381% | +$433K | ﹤0.01% | 1004 |
|
|
2023
Q4 | $99K | Buy |
+2,545
| New | +$99K | ﹤0.01% | 1281 |
|
|
2022
Q1 | – | Sell |
-775
| Closed | -$120K | – | 2403 |
|
|
2021
Q4 | $120K | Buy |
+775
| New | +$120K | ﹤0.01% | 1882 |
|
|
2021
Q3 | – | Sell |
-1,035
| Closed | -$336K | – | 2340 |
|
|
2021
Q2 | $336K | Buy |
+1,035
| New | +$336K | ﹤0.01% | 1602 |
|